Climb Bio, Inc. (CLYM) Tops Q1 EPS by 9c

Climb Bio, Inc. (NASDAQ: CLYM) reported Q1 EPS of ($0.20), $0.09 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• Freedom Broker Upgrades Core Scientific Inc. (CORZ) to Buy
• Deepseek Is Developing Massive Ai Data Center In Inner Mongolia - Bloomberg
• Situational Awareness has not sold stake in Anthropic - Reuters